Eric Eugene Esser - 04 Aug 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Reporting relationship: Chief Operating Officer
Issuer ticker: TBIO
Reported as of: 04 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Aug 2022, 16:03:03 UTC
Prior SEC filing: 17 Jun 2022
Next SEC filing: 05 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Rob Cutler, as Attorney-in-Fact

Key filing fact

Eric Eugene Esser filed Form 4 for Codex DNA, Inc. (TBIO) on 08 Aug 2022.

Key facts

This page summarizes Eric Eugene Esser's Form 4 filing for Codex DNA, Inc. (TBIO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Aug 2022, 16:03.

Change

Previous filing in this sequence was filed on 17 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TBIO transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 04 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $2.08
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on August 4, 2024.